1. Short title This Act may be cited as the Shandra Eisenga Human Cell and Tissue Product Safety Act . 2. Definitions In this Act: (1) Human cell and tissue establishment The term human cell and tissue establishment means an establishment (as defined in section 1271.3(b) of title 21, Code of Federal Regulations (or a successor regulation)) regulated by the Center for Biologics Evaluation and Research under part 1271 of title 21, Code of Federal Regulations. (2) Human cell and tissue products The term human cell and tissue products has the meaning given the term human cells, tissues, or cellular or tissue-based products in section 1271.3(d) of title 21, Code of Federal Regulations (or a successor regulation). (3) Secretary The term Secretary means the Secretary of Health and Human Services. 3. Human cell and tissue products transplant public awareness campaign (a) In general The Secretary shall conduct a national, evidence-based education campaign to increase public and health care provider awareness regarding the potential risks and benefits of human cell and tissue products transplants. (b) Consideration of advice of stakeholder experts The Secretary shall develop the education campaign under subsection (a) after taking into consideration the advice of stakeholder experts, including the Centers for Disease Control and Prevention and professional associations that represent stakeholders of human cell and tissue establishments that manufacture human cell and tissue products with the highest risk of transmitting infections to their patients. (c) Grants (1) In general The Secretary may award grants to nonprofit organizations to carry out activities described in paragraph (2). (2) Use of funds A recipient of a grant under paragraph (1) shall use the grant funds— (A) to increase the knowledge and awareness of the public about the potential risks and benefits of human cell and tissue products transplants, including the risks that such transplants may lead to infectious diseases, including tuberculosis, latent